Yang, David D.
Buscariollo, Daniela L.
Cronin, Angel M.
Weng, Shicheng
Hughes, Melissa E.
Bleicher, Richard J.
Cohen, Adam L.
Javid, Sara H.
Edge, Stephen B.
Moy, Beverly
Niland, Joyce C.
Wolff, Antonio C.
Hassett, Michael J.
Punglia, Rinaa S.
Article History
Received: 4 May 2020
Accepted: 10 August 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: Institutional review board approval from the Dana-Farber/Harvard Cancer Center was obtained before undertaking this study.
: Not applicable.
: Adam Cohen reports receiving grants from Novartis, AbbVie, Merrimack, Bristol-Myers Squibb, Eli Lilly, Pfizer, and Cascadia, outside the submitted work. Richard Bleicher reports receiving personal fees from Genomic Health, outside the submitted work. All other authors have no relevant disclosures.